APA (7th ed.) Citation

K, M., R, K., M, S., T, O., T, T., M, F., . . . K, M. (2025). Efficacy of third-line chemotherapy following nanoliposomal irinotecan combined with fluorouracil and folinic acid as second-line treatment for unresectable pancreatic cancer. Frontiers in oncology, 15, 1626689. https://doi.org/10.3389/fonc.2025.1626689

Chicago Style (17th ed.) Citation

K, Miwa, et al. "Efficacy of Third-line Chemotherapy Following Nanoliposomal Irinotecan Combined with Fluorouracil and Folinic Acid as Second-line Treatment for Unresectable Pancreatic Cancer." Frontiers in Oncology 15 (2025): 1626689. https://doi.org/10.3389/fonc.2025.1626689.

MLA (9th ed.) Citation

K, Miwa, et al. "Efficacy of Third-line Chemotherapy Following Nanoliposomal Irinotecan Combined with Fluorouracil and Folinic Acid as Second-line Treatment for Unresectable Pancreatic Cancer." Frontiers in Oncology, vol. 15, 2025, p. 1626689, https://doi.org/10.3389/fonc.2025.1626689.